BSE filing, BSE: 543848. Summary written from the filing by ALFA Finder's alert engine.
Dev Labtech Venture Ltd: key numbers
- Share price
- ₹22.90
- Market cap
- ₹108.7 Cr
- Revenue (annual)
- ₹167.2 Cr
- Net profit (annual)
- ₹9.57 Cr
- P/E (TTM)
- 11.4×Sector 49.5×
- Promoter holding
- 56.69%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dev Labtech Venture Ltd
All →Dev Labtech Venture Other Announcement
Dev Labtech Venture Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Dev Labtech Venture Convertible Warrants
Dev Labtech Venture will hold an EGM to approve the preferential issue of 1.37 crore convertible warrants, raising ₹17.81 Crore.
- Value
- ₹17.81 Cr
Dev Labtech Venture Capital Structure Change
Dev Labtech Venture Limited announced an increase in authorized share capital from 50 million to 62 million equity shares, each with a face value of Rs 5.
Dev Labtech Venture Fund Raise of ₹17.81 Cr
Dev Labtech Venture approved the preferential issue of 1.37 crore convertible warrants aggregating ₹17.81 crore. The company also increased its authorised share capital for future expansion.
- Value
- ₹17.81 Cr
Dev Labtech Venture Annual General Meeting
Dev Labtech Venture Limited held its 33rd Annual General Meeting on September 26, 2026. Members considered the adoption of financial statements, director appointment, and related party transactions.
Dev Labtech Venture Debt & Borrowing: ₹2.1 Cr
Dev Labtech executed a ₹2.10 Cr working capital facility with HDFC Bank at 8.9% floating interest. The 12-month overdraft is secured against residential and commercial property.
- Value
- ₹2.10 Cr
- Execution
- 12 months, repayable on demand, subject to annual renewal
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.